Literature DB >> 26870341

Study of the biological features of in vitro cultured γδ T cells.

Yan Zhang1, Liming Zhi1, Zan Zhang1.   

Abstract

The aim of the present study was to investigate the biological features of in vitro cultured γδ T cells. The γδ T cells were in vitro cultured and on different culture days cell proliferation, phenotype, killing activity and the secretion of cytokines were analyzed. Cell numbers were counted by an automated cell counter, phenotype of the cells and cytokines were analyzed by flow cytometry, and killing activities of the cells against gastric cancer SGC-7901 cells were tested using the cell counting kit-8. From days 7 to 14, in vitro cultured γδ T cells enter the exponential phase. On day 14, maximum proliferation fold was observed, and on day 10, the maximum specific growth rate µmax was achieved. Flow phenotype cluster of differentiation 3+-T-cell receptor γδ+ of the γδ T cells in the first 7-17 days achieved a higher proportion and showed no significant differences between 10 days. Secretion of the cytokines interferon-γ and tumor necrosis factor-α gradually increased in the first 7-14 days. The maximum was achieved on day 14, and subsequently began to decrease. The cytolytic activity of the γδ T cells to kill the SGC-7901 cells in the first 7-14 days had an improved killing effect, a slight decline from the first 17 days; in the effector cell to target cell (E:T) ratio 20:1, 10:1 and 5:1 conditions, γδ T cells kill SGC-7901 cells more effectively than 1:1 and 1:2. In conclusion, γδ T cells cultured in the first 7-14 days are suitable for clinical transfusion, and the optimal transfusion time is day 10. An E:T ratio >5:1 is preferred.

Entities:  

Keywords:  cytokine; cytolytic activity; effector cell to target cell ratio; phenotype; proliferation; γδ T cells

Year:  2015        PMID: 26870341      PMCID: PMC4726913          DOI: 10.3892/br.2015.538

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  9 in total

Review 1.  Gammadelta T cells: functional plasticity and heterogeneity.

Authors:  Simon R Carding; Paul J Egan
Journal:  Nat Rev Immunol       Date:  2002-05       Impact factor: 53.106

Review 2.  Perspectives of gammadelta T cells in tumor immunology.

Authors:  Dieter Kabelitz; Daniela Wesch; Wei He
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

3.  Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.

Authors:  Emilie Viey; Gaëlle Fromont; Bernard Escudier; Yannis Morel; Sylvie Da Rocha; Salem Chouaib; Anne Caignard
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

Review 4.  γδ T-cell immunotherapy for lung cancer.

Authors:  Yukihiro Yoshida; Jun Nakajima; Hiromi Wada; Kazuhiro Kakimi
Journal:  Surg Today       Date:  2011-05-01       Impact factor: 2.549

Review 5.  gammadelta T cells link innate and adaptive immune responses.

Authors:  Wolfgang Holtmeier; Dieter Kabelitz
Journal:  Chem Immunol Allergy       Date:  2005

Review 6.  Aminobisphosphonate-activated gammadelta T cells in immunotherapy of cancer: doubts no more.

Authors:  Nadia Caccamo; Serena Meraviglia; Francesco Scarpa; Carmela La Mendola; Daniele Santini; Cesira T Bonanno; Gabriella Misiano; Francesco Dieli; Alfredo Salerno
Journal:  Expert Opin Biol Ther       Date:  2008-07       Impact factor: 4.388

7.  Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models.

Authors:  Eva Rettinger; Vida Meyer; Hermann Kreyenberg; Andreas Volk; Selim Kuçi; Andre Willasch; Ewa Koscielniak; Simone Fulda; Winfried S Wels; Halvard Boenig; Thomas Klingebiel; Peter Bader
Journal:  Front Oncol       Date:  2012-04-09       Impact factor: 6.244

Review 8.  Human gamma delta T cells: candidates for the development of immunotherapeutic strategies.

Authors:  Susann Beetz; Lothar Marischen; Dieter Kabelitz; Daniela Wesch
Journal:  Immunol Res       Date:  2007       Impact factor: 4.505

9.  Gamma delta T cells provide an early source of interferon gamma in tumor immunity.

Authors:  Yunfei Gao; Wancai Yang; Meng Pan; Eileen Scully; Michael Girardi; Leonard H Augenlicht; Joe Craft; Zhinan Yin
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.